Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Guillain-Barré Syndrome market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Guillain-Barré Syndromemarket, defines the market attractiveness level of Guillain-Barré Syndrome market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Guillain-Barré Syndrome industry, describes the types of Guillain-Barré Syndrome market, the applications of major players and the market size, and deeply analyzes the current situation of the global Guillain-Barré Syndrome market and the development prospects and opportunities of Guillain-Barré Syndrome industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Guillain-Barré Syndrome market in Chapter 13.
By Player:
Akari Therapeutics
CSL Behring
Biotest
Grifols
Octapharma
Nihon Pharmaceutical
Kedrion
China Biologic Products Holdings
By Type:
Intravenous Immunoglobulin
Plasma Exchange
Analgesics
Anticonvulsants
LMWH
By End-User:
Hospital Pharmacies
Retail Pharmacies
Home Care
Clinics
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Guillain-Barré Syndrome Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Guillain-Barré Syndrome Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Guillain-Barré Syndrome Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Guillain-Barré Syndrome Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Guillain-Barré Syndrome Market Analysis and Outlook to 2022
-
7.1 Global Guillain-Barré Syndrome Consumption (2017-2022)
-
7.2 United States Guillain-Barré Syndrome Consumption (2017-2022)
-
7.3 Europe Guillain-Barré Syndrome Consumption (2017-2022)
-
7.4 China Guillain-Barré Syndrome Consumption (2017-2022)
-
7.5 Japan Guillain-Barré Syndrome Consumption (2017-2022)
-
7.6 India Guillain-Barré Syndrome Consumption (2017-2022)
-
7.7 South Korea Guillain-Barré Syndrome Consumption (2017-2022)
8 Region and Country-wise Guillain-Barré Syndrome Market Analysis and Outlook to 2028
-
8.1 Global Guillain-Barré Syndrome Consumption Forecast (2022-2028)
-
8.2 United States Guillain-Barré Syndrome Consumption Forecast (2022-2028)
-
8.3 Europe Guillain-Barré Syndrome Consumption Forecast (2022-2028)
-
8.4 China Guillain-Barré Syndrome Consumption Forecast (2022-2028)
-
8.5 Japan Guillain-Barré Syndrome Consumption Forecast (2022-2028)
-
8.6 India Guillain-Barré Syndrome Consumption Forecast (2022-2028)
-
8.7 South Korea Guillain-Barré Syndrome Consumption Forecast (2022-2028)
9 Global Guillain-Barré Syndrome Market Outlook by Types and Applications to 2022
-
9.1 Global Guillain-Barré Syndrome Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Intravenous Immunoglobulin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Plasma Exchange Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Analgesics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Anticonvulsants Consumption and Growth Rate (2017-2022)
-
9.1.5 Global LMWH Consumption and Growth Rate (2017-2022)
-
9.2 Global Guillain-Barré Syndrome Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Home Care Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Clinics Consumption and Growth Rate (2017-2022)
10 Global Guillain-Barré Syndrome Market Outlook by Types and Applications to 2028
-
10.1 Global Guillain-Barré Syndrome Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Intravenous Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Plasma Exchange Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global LMWH Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Guillain-Barré Syndrome Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
11 Global Guillain-Barré Syndrome Import and Export Analysis (Top 5 Countries)
-
11.1 Global Guillain-Barré Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Guillain-Barré Syndrome Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Guillain-Barré Syndrome Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Guillain-Barré Syndrome Market Competitive Analysis
-
14.1 Akari Therapeutics
-
14.1.1 Akari Therapeutics Company Details
-
14.1.2 Akari Therapeutics Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Akari Therapeutics Guillain-Barré Syndrome Product and Service
-
14.2 CSL Behring
-
14.2.1 CSL Behring Company Details
-
14.2.2 CSL Behring Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 CSL Behring Guillain-Barré Syndrome Product and Service
-
14.3 Biotest
-
14.3.1 Biotest Company Details
-
14.3.2 Biotest Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Biotest Guillain-Barré Syndrome Product and Service
-
14.4 Grifols
-
14.4.1 Grifols Company Details
-
14.4.2 Grifols Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Grifols Guillain-Barré Syndrome Product and Service
-
14.5 Octapharma
-
14.5.1 Octapharma Company Details
-
14.5.2 Octapharma Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Octapharma Guillain-Barré Syndrome Product and Service
-
14.6 Nihon Pharmaceutical
-
14.6.1 Nihon Pharmaceutical Company Details
-
14.6.2 Nihon Pharmaceutical Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Nihon Pharmaceutical Guillain-Barré Syndrome Product and Service
-
14.7 Kedrion
-
14.7.1 Kedrion Company Details
-
14.7.2 Kedrion Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Kedrion Guillain-Barré Syndrome Product and Service
-
14.8 China Biologic Products Holdings
-
14.8.1 China Biologic Products Holdings Company Details
-
14.8.2 China Biologic Products Holdings Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 China Biologic Products Holdings Guillain-Barré Syndrome Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Guillain-Barré Syndrome
-
Figure Guillain-Barré Syndrome Picture
-
Table Global Guillain-Barré Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Guillain-Barré Syndrome Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Guillain-Barré Syndrome Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Guillain-Barré Syndrome Consumption by Country (2017-2022)
-
Figure United States Guillain-Barré Syndrome Consumption and Growth Rate (2017-2022)
-
Table Europe Guillain-Barré Syndrome Consumption and Growth Rate (2017-2022)
-
Figure China Guillain-Barré Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Japan Guillain-Barré Syndrome Consumption and Growth Rate (2017-2022)
-
Figure India Guillain-Barré Syndrome Consumption and Growth Rate (2017-2022)
-
Figure South Korea Guillain-Barré Syndrome Consumption and Growth Rate (2017-2022)
-
Figure Global Guillain-Barré Syndrome Consumption Forecast by Country (2022-2028)
-
Figure United States Guillain-Barré Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Guillain-Barré Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Guillain-Barré Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Guillain-Barré Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Guillain-Barré Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Guillain-Barré Syndrome Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Intravenous Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure Global Plasma Exchange Consumption and Growth Rate (2017-2022)
-
Figure Global Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure Global LMWH Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Home Care Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Intravenous Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Plasma Exchange Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LMWH Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Home Care Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Guillain-Barré Syndrome Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Guillain-Barré Syndrome Export by Region (Top 5 Countries) (2017-2028)
-
Table Akari Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Akari Therapeutics Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akari Therapeutics Guillain-Barré Syndrome Product and Service
-
Table CSL Behring (Foundation Year, Company Profile and etc.)
-
Table CSL Behring Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Behring Guillain-Barré Syndrome Product and Service
-
Table Biotest (Foundation Year, Company Profile and etc.)
-
Table Biotest Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biotest Guillain-Barré Syndrome Product and Service
-
Table Grifols (Foundation Year, Company Profile and etc.)
-
Table Grifols Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Grifols Guillain-Barré Syndrome Product and Service
-
Table Octapharma (Foundation Year, Company Profile and etc.)
-
Table Octapharma Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Octapharma Guillain-Barré Syndrome Product and Service
-
Table Nihon Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Nihon Pharmaceutical Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nihon Pharmaceutical Guillain-Barré Syndrome Product and Service
-
Table Kedrion (Foundation Year, Company Profile and etc.)
-
Table Kedrion Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kedrion Guillain-Barré Syndrome Product and Service
-
Table China Biologic Products Holdings (Foundation Year, Company Profile and etc.)
-
Table China Biologic Products Holdings Guillain-Barré Syndrome Sales, Price, Value and Gross Profit (2017-2022)
-
Table China Biologic Products Holdings Guillain-Barré Syndrome Product and Service
-
